Formulary Restrictions May Worsen Atrial Fibrillation Outcomes
Risk for adverse health outcomes higher for patients with Medicare Part D plans limiting access to non-vitamin K antagonist oral anticoagulants
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.